BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bayram F, Kocer D, Gundogan K, Kaya A, Demir O, Coskun R, Sabuncu T, Karaman A, Cesur M, Rizzo M, Toth PP, Gedik V. Prevalence of dyslipidemia and associated risk factors in Turkish adults. J Clin Lipidol 2014;8:206-16. [PMID: 24636181 DOI: 10.1016/j.jacl.2013.12.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Davidović DB, Tomić DV, Paunović KŽ, Vasiljević ND, Jorga JB. Nutrition labelling of pre-packaged foods in Belgrade, Serbia: current situation. Public Health Nutr 2015;18:1969-78. [PMID: 25374093 DOI: 10.1017/S1368980014002353] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Aryan Z, Mahmoudi N, Sheidaei A, Rezaei S, Mahmoudi Z, Gohari K, Rezaei N, Hajipour MJ, Dilmaghani-Marand A, Razi F, Sabooni M, Kompani F, Delavari A, Larijani B, Farzadfar F. The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016. J Clin Lipidol 2018;12:1471-1481.e4. [PMID: 30195823 DOI: 10.1016/j.jacl.2018.08.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
3 Shi W, Wang Q, Choi W, Li J. Mapping and Congenic Dissection of Genetic Loci Contributing to Hyperglycemia and Dyslipidemia in Mice. PLoS One 2016;11:e0148462. [PMID: 26859786 DOI: 10.1371/journal.pone.0148462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Cure E, Cumhur Cure M. Comment on “The relationship between atherogenic index of plasma and no‑reflow in patients with acute ST‑segment elevation myocardial infarction who underwent primary percutaneous coronary intervention”. Int J Cardiovasc Imaging 2020;36:797-8. [DOI: 10.1007/s10554-020-01781-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lin HQ, Wu JY, Chen ML, Chen FQ, Liao YJ, Wu YT, Guo ZJ. Prevalence of dyslipidemia and prediction of 10-year CVD risk among older adults living in southeast coastal regions in China: a cross-sectional study. Clin Interv Aging 2019;14:1119-29. [PMID: 31354254 DOI: 10.2147/CIA.S207665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Krishnadath IS, Nahar-van Venrooij LM, Jaddoe VW, Toelsie JR. Ethnic differences in prediabetes and diabetes in the Suriname Health Study. BMJ Open Diabetes Res Care 2016;4:e000186. [PMID: 27403324 DOI: 10.1136/bmjdrc-2015-000186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
7 Gazzola K, Reeskamp L, van den Born B. Ethnicity, lipids and cardiovascular disease: . Current Opinion in Lipidology 2017;28:225-30. [DOI: 10.1097/mol.0000000000000412] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
8 Stoian AP, Kempler P, Stulnig T, Rizvi AA, Rizzo M. Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us. Metab Syndr Relat Disord 2021. [PMID: 34967689 DOI: 10.1089/met.2021.0133] [Reference Citation Analysis]
9 Supiyev A, Nurgozhin T, Zhumadilov Z, Peasey A, Hubacek JA, Bobak M. Prevalence, awareness, treatment and control of dyslipidemia in older persons in urban and rural population in the Astana region, Kazakhstan. BMC Public Health 2017;17:651. [PMID: 28800751 DOI: 10.1186/s12889-017-4629-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
10 Ionescu M, Stoian AP, Rizzo M, Serban D, Nuzzo D, Mazilu L, Suceveanu AI, Dascalu AM, Parepa IR. The Role of Endothelium in COVID-19. Int J Mol Sci 2021;22:11920. [PMID: 34769350 DOI: 10.3390/ijms222111920] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Rizvi AA, Janez A, Rizzo M. Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues. Int J Mol Sci 2021;22:12311. [PMID: 34830193 DOI: 10.3390/ijms222212311] [Reference Citation Analysis]
12 Gazzola K, Snijder MB, Hovingh GK, Stroes ES, Peters RJ, van den Born BH. Ethnic differences in plasma lipid levels in a large multiethnic cohort: The HELIUS study. Journal of Clinical Lipidology 2018;12:1217-1224.e1. [DOI: 10.1016/j.jacl.2018.06.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Yang X, Xu C, Wang Y, Cao C, Tao Q, Zhan S, Sun F. Risk prediction model of dyslipidaemia over a 5-year period based on the Taiwan MJ health check-up longitudinal database. Lipids Health Dis 2018;17:259. [PMID: 30447693 DOI: 10.1186/s12944-018-0906-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Tokgozoglu L, Kayikcioglu M, Ekinci B. The landscape of preventive cardiology in Turkey: Challenges and successes. Am J Prev Cardiol 2021;6:100184. [PMID: 34327504 DOI: 10.1016/j.ajpc.2021.100184] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Alzaheb RA, Altemani AH. Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia. Diabetes Metab Syndr Obes 2020;13:4033-40. [PMID: 33149642 DOI: 10.2147/DMSO.S246068] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Kwon YJ, Lee JW, Kang HT. Secular Trends in Lipid Profiles in Korean Adults Based on the 2005-2015 KNHANES. Int J Environ Res Public Health 2019;16:E2555. [PMID: 31319575 DOI: 10.3390/ijerph16142555] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
17 Abdu A, Cheneke W, Adem M, Belete R, Getachew A. Dyslipidemia and Associated Factors Among Patients Suspected to Have Helicobacter pylori Infection at Jimma University Medical Center, Jimma, Ethiopia. Int J Gen Med 2020;13:311-21. [PMID: 32606896 DOI: 10.2147/IJGM.S243848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lian Y, Xie L, Liu Y, Tang F. Metabolic-related markers and inflammatory factors as predictors of dyslipidemia among urban Han Chinese adults. Lipids Health Dis 2019;18:167. [PMID: 31472689 DOI: 10.1186/s12944-019-1109-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Malta DC, Szwarcwald CL, Machado ÍE, Pereira CA, Figueiredo AW, Sá ACMGN, Velasquez-Melendez G, Santos FMD, Souza Junior PB, Stopa SR, Rosenfeld LG. Prevalence of altered total cholesterol and fractions in the Brazilian adult population: National Health Survey. Rev Bras Epidemiol 2019;22Suppl 02:E190005.SUPL.2. [PMID: 31596376 DOI: 10.1590/1980-549720190005.supl.2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Gu X, Li C, He J, Li S, Bazzano LA, Kinchen JM, Chen W, He H, Gu D, Kelly TN. Serum metabolites associate with lipid phenotypes among Bogalusa Heart Study participants. Nutr Metab Cardiovasc Dis 2020;30:777-87. [PMID: 32131987 DOI: 10.1016/j.numecd.2020.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Savla JJ, Levine BD, Sadek HA. The Effect of Hypoxia on Cardiovascular Disease: Friend or Foe? High Alt Med Biol 2018;19:124-30. [PMID: 29939783 DOI: 10.1089/ham.2018.0044] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
22 Abujbara M, Batieha A, Khader Y, Jaddou H, El-Khateeb M, Ajlouni K. The Prevalence of Dyslipidemia among Jordanians. J Lipids 2018;2018:6298739. [PMID: 30510803 DOI: 10.1155/2018/6298739] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
23 Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol 2021. [PMID: 33833450 DOI: 10.1038/s41569-021-00541-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
24 Yu S, Yang H, Guo X, Zhang X, Zheng L, Sun Y. Prevalence of dyslipidemia and associated factors among the hypertensive population from rural Northeast China. BMC Public Health 2015;15:1152. [PMID: 26589291 DOI: 10.1186/s12889-015-2486-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhu Q, Wang XB, Yao Y, Ning CX, Chen XP, Luan FX, Zhao YL. Association between anthropometric measures and cardiovascular disease (CVD) risk factors in Hainan centenarians: investigation based on the Centenarian's health study. BMC Cardiovasc Disord 2018;18:73. [PMID: 29716519 DOI: 10.1186/s12872-018-0810-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
26 Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, Zhao Z, Zhang Y, Wang L. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults. Int J Cardiol 2018;260:196-203. [PMID: 29622441 DOI: 10.1016/j.ijcard.2017.12.069] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 11.8] [Reference Citation Analysis]
27 Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, Asghari G, Parizadeh D, Montazeri SA, Lotfaliany M, Takyar F, Khalili D. Metabolic health in the Middle East and north Africa.Lancet Diabetes Endocrinol. 2019;7:866-879. [PMID: 31422063 DOI: 10.1016/S2213-8587(19)30179-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
28 Latifi SM, Moradi L, Shahbazian H, Aleali AM. A study of the prevalence of dyslipidemia among the adult population of Ahvaz, Iran. Diabetes Metab Syndr 2016;10:190-3. [PMID: 27377682 DOI: 10.1016/j.dsx.2016.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
29 Abdulhai F, Jaffa MA, Elias J, Zakka P, Hotait M, Bou-Fakhredin R, Arnaout S, Taher AT, Refaat MM. Digital thermography and vascular involvement in β-thalassemia intermedia. Ann Hematol 2021. [PMID: 34235558 DOI: 10.1007/s00277-021-04588-8] [Reference Citation Analysis]
30 Ni WQ, Liu XL, Zhuo ZP, Yuan XL, Song JP, Chi HS, Xu J. Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen. Lipids Health Dis 2015;14:71. [PMID: 26168792 DOI: 10.1186/s12944-015-0073-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
31 Sá ACMGN, Machado ÍE, Bernal RTI, Malta DC. Factors associated with high LDL-Cholesterol in the Brazilian adult population: National Health Survey. Cien Saude Colet 2021;26:541-53. [PMID: 33605332 DOI: 10.1590/1413-81232021262.37102020] [Reference Citation Analysis]
32 Min HK, Kim SH, Choi JH, Choi K, Kim HR, Lee SH. Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data. World J Clin Cases 2021; 9(33): 10198-10207 [PMID: 34904090 DOI: 10.12998/wjcc.v9.i33.10198] [Reference Citation Analysis]
33 Rizvi AA, Stoian AP, Janez A, Rizzo M. Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options. Biomedicines 2021;9:1579. [PMID: 34829807 DOI: 10.3390/biomedicines9111579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Mohammadbeigi A, Moshiri E, Mohammadsalehi N, Ansari H, Ahmadi A. Dyslipidemia Prevalence in Iranian Adult Men: The Impact of Population-Based Screening on the Detection of Undiagnosed Patients. World J Mens Health 2015;33:167-73. [PMID: 26770936 DOI: 10.5534/wjmh.2015.33.3.167] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
35 Sözmen K, Ünal B, Sakarya S, Dinç G, Yardım N, Keskinkılıç B, Ergör G. Determinants of prevalence, awareness, treatment and control of high LDL-C in Turkey. Anatol J Cardiol 2016;16:370-84. [PMID: 27282671 DOI: 10.14744/AnatolJCardiol.2016.7018] [Reference Citation Analysis]
36 Fan Y, Huang JJ, Sun CM, Qiao N, Zhang HX, Wang H, Tao R, Shen YN, Wang T. Prevalence of dyslipidaemia and risk factors in Chinese coal miners: a cross-sectional survey study. Lipids Health Dis 2017;16:161. [PMID: 28835245 DOI: 10.1186/s12944-017-0548-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
37 Tang F, Wang J, Nicholas S, Qian D, Liu R. A cohort study on risk factors of high-density lipoprotein cholesterol hypolipidemia among urban Chinese adults. Lipids Health Dis 2021;20:20. [PMID: 33618731 DOI: 10.1186/s12944-021-01449-1] [Reference Citation Analysis]
38 Farhat A, Al-Hajje A, Rachidi S, Zein S, Zeid MB, Salameh P, Bawab W, Awada S. Risk factors and quality of life of dyslipidemic patients in Lebanon: A cross-sectional study. J Epidemiol Glob Health 2016;6:315-23. [PMID: 27842211 DOI: 10.1016/j.jegh.2016.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
39 Zhang A, Yao Y, Xue Z, Guo X, Dou J, Lv Y, Shen L, Yu Y, Jin L. A Study on the Factors Influencing Triglyceride Levels among Adults in Northeast China. Sci Rep 2018;8:6388. [PMID: 29686322 DOI: 10.1038/s41598-018-24230-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
40 Lotufo PA, Santos RD, Figueiredo RM, Pereira AC, Mill JG, Alvim SM, Fonseca MJ, Almeida MC, Molina MC, Chor D, Schmidt MI, Ribeiro AL, Duncan BB, Bensenor IM. Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: Baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J Clin Lipidol 2016;10:568-76. [PMID: 27206944 DOI: 10.1016/j.jacl.2015.12.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
41 Yuan X, Ni W, Wang R, Chi H, Sun Y, Lv D, Liu P, Xu J. 6-Year trends in lipids among adults in Shenzhen, China. J Public Health (Oxf) 2020;42:e468-76. [PMID: 31728508 DOI: 10.1093/pubmed/fdz113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 Lao J, Liu Y, Yang Y, Peng P, Ma F, Ji S, Chen Y, Tang F. Time series decomposition into dyslipidemia prevalence among urban Chinese population: secular and seasonal trends. Lipids Health Dis 2021;20:114. [PMID: 34551767 DOI: 10.1186/s12944-021-01541-6] [Reference Citation Analysis]
43 Banerjee Y, Pantea Stoian A, Cicero AFG, Fogacci F, Nikolic D, Sachinidis A, Rizvi AA, Janez A, Rizzo M. Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia. Expert Opin Drug Saf 2021;:1-12. [PMID: 34596005 DOI: 10.1080/14740338.2022.1988568] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Balanova YA, Shalnova SA, Deev AD, Imaeva AE, Kontsevaya AV, Muromtseva GA, Kapustina АV, Evstifeeva SE, Drapkina ОM. OBESITY IN RUSSIAN POPULATION — PREVALENCE AND ASSOCIATION WITH THE NON-COMMUNICABLE DISEASES RISK FACTORS. Russ J Cardiol 2018. [DOI: 10.15829/1560-4071-2018-6-123-130] [Cited by in Crossref: 32] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
45 Ali I, Kharma A, Samara M, Odeh S, Jaradat N, Zaid AN, Ahmad MAS. Prevalence of Dyslipidemia in Undiagnosed Palestinian Men: A Cross-Sectional Study. J Lipids 2019;2019:3473042. [PMID: 31737369 DOI: 10.1155/2019/3473042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Al-Duais MA, Al-Awthan YS. Association between qat chewing and dyslipidaemia among young males. J Taibah Univ Med Sci 2019;14:538-46. [PMID: 31908642 DOI: 10.1016/j.jtumed.2019.09.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Nie F, Wang Z, Zeng Q, Guan H, Yang J, Luo P, Du L, Wang J, Hong F. Health behaviors and metabolic risk factors are associated with dyslipidemia in ethnic Miao Chinese adults: the China multi-ethnic cohort study. BMC Public Health 2021;21:851. [PMID: 33941138 DOI: 10.1186/s12889-021-10871-0] [Reference Citation Analysis]
48 Donmez-Altuntas H, Bayram F, Coskun-Demirkalp AN, Baspınar O, Kocer D, Toth PP. Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients. Exp Biol Med (Maywood) 2019;244:1089-95. [PMID: 31426681 DOI: 10.1177/1535370219871895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]